Children’s Hospital Los Angeles Appoints Mitchell Geffner, MD, as Division Chief at the Center for Endocrinology, Diabetes and Metabolism
Former Interim Chief Leads Center that is Ranked Fifth in Nation for Pediatric Endocrinology and Diabetes Care by U.S. News & World Report
|Mitchell E. Geffner, MD, has been appointed division chief and director of fellowship training for the Center for Endocrinology, Diabetes, and Metabolism at Children’s Hospital Los Angeles.
Contact: Brian Greene at 323-361-4823
LOS ANGELES (February 6, 2012) – Mitchell E. Geffner, MD, has been appointed division chief and director of fellowship training for the Center for Endocrinology, Diabetes, and Metabolism at Children’s Hospital Los Angeles. The Center is among the nation’s best and is ranked fifth nationally for pediatric endocrinology and diabetes care by U.S. News & World Report.
“Dr. Geffner has made innumerable contributions to our hospital during the past decade as a member of the endocrinology team and has done an outstanding job in his role as the interim division chief of the Center,” said Richard D. Cordova, FACHE, president and CEO, Children’s Hospital Los Angeles. “I am extremely pleased that Dr. Geffner has accepted this full-time appointment as division chief.”
The Center for Endocrinology, Diabetes, and Metabolism provides clinical care and also conducts research on childhood diabetes, growth, weight management, general endocrinology and bone metabolism. The center cares for more than 4,000 children with endocrine disorders annually. Nearly 2,000 patients are treated each year for type-1 and type-2 diabetes. The center continues to pioneer new tools, treatments and lifestyle-changing clinical programs. Geffner, who specializes in endocrinology and metabolism, previously served as interim division chief of the center and has been a member of the medical staff at Children’s Hospital Los Angeles since 2002.
“Our team of professionals in endocrinology, diabetes and metabolism is working on multiple fronts to advance early intervention, education and scientific investigation to continue to give the children we care for a better quality of life,” said D. Brent Polk, MD, professor and chair of the Department of Pediatrics and director of the Saban Research Institute of Children’s Hospital Los Angeles. “We are honored to have Dr. Geffner overseeing all of these great efforts by this wonderful team.”
Geffner’s responsibilities also include serving as a professor of Pediatrics at the Keck School of Medicine of the University of Southern California, which has been affiliated with Children’s Hospital Los Angeles since 1932 and is also one of the nation’s premier teaching hospitals.
"We are fortunate that Dr. Geffner is taking on this dynamic leadership role with Children’s Hospital Los Angeles in conjunction with his role at the university,” said Carmen A. Puliafito, MD, MBA, dean of the Keck School of Medicine of USC, and a member of the Board of Trustees at Children’s Hospital Los Angeles. “His dedication to medicine, research and education will have a tremendous impact on patients, residents and clinicians for years to come.”
Geffner’s educational background includes graduating from the Albert Einstein College of Medicine (1975); completing his residency at the LAC-USC Medical Center (1975-1979); and fulfilling his fellowship in Pediatric Endocrinology at the University of California Los Angeles (1979-1982). He remained at UCLA through 2001, rising up the academic ladder to the rank of professor in 1996. Geffner has been recognized with numerous awards during his career, including being selected in 2011 as one of the nation’s Top Doctors by U.S. News and World Report for being among the top 1 percent of all pediatric endocrinologists in the country.
Geffner’s clinical interests include disorders of growth and puberty, adrenal hyperplasia and he is involved in studies of new formulations, delivery systems and indications for growth-promoting therapies. His longstanding basic science research interest is in the general area of hormone resistance. Geffner is the principal investigator at Children’s Hospital Los Angeles for the Treatment Options for type 2 diabetes in Adolescents and Youth (TODAY) trial sponsored by the National Institutes of Health. He is also national endocrinology consultant to the NIH-sponsored Pediatric HIV/AIDS Cohort Study (PHACS) of adolescents with HIV infection and uninfected children exposed to anti-retroviral therapy in utero.
Geffner has had a career-long interest in medical and patient education. He recently finished a three-year term as an elected member of the board of directors of the Pediatric Endocrine Society (PES); is chair of the American Board of Pediatrics Sub-Board on Pediatric Endocrinology; serves as medical advisor on childhood panhypo-pituitarism for the MAGIC Foundation and the Pituitary Network Association; and participates as a member of the Scientific Advisory Board of the CARES Foundation.
Geffner is the author of more than 110 research articles. He serves as pediatric endocrinology editor for UpToDate; as associate editor of the journal Pediatric Endocrinology Reviews; and as co-editor of the new textbook “Pediatric Practice: Endocrinology” recently published and distributed by McGraw-Hill.
About Children’s Hospital Los Angeles
Children's Hospital Los Angeles has been named the best children’s hospital in California and among the best in the nation for clinical excellence with its selection to the prestigious US News & World Report Honor Roll. Children’s Hospital is home to The Saban Research Institute, one of the largest and most productive pediatric research facilities in the United States. The hospital is also one of America's premier teaching hospitals through its affiliation since 1932 with the Keck School of Medicine of the University of Southern California. For more information, visit CHLA.org. Follow us on Twitter, Facebook, YouTube and LinkedIn, or visit our blog: WeAreChildrens.org.